Related Experiment Video
Updated: May 15, 2026

06:12
Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
Multiplexed surface plasmon resonance imaging for protein biomarker analysis
Eric Ouellet1, Louise Lund, Eric T Lagally
1Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|January 19, 2013
Summary
This study presents a novel microfluidic Surface Plasmon Resonance Imaging (SPRi) instrument for sensitive, label-free detection of molecular binding. The system successfully identified the cancer biomarker activated leukocyte cell adhesion molecule (ALCAM) in human cell lysates.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Proteomics
Background:
- Reliable detection of ligand and analyte binding is crucial for medical diagnostics.
- Advances in proteomics necessitate advanced techniques for identifying protein biomarkers in complex samples.
- Surface Plasmon Resonance Imaging (SPRi) offers label-free, real-time detection of molecular interactions.
Purpose of the Study:
- To detail the fabrication of a novel SPR imaging instrument.
- To demonstrate the instrument's capability for analyzing molecular binding interactions.
- To enable multiplexed analysis and biomarker identification from complex biological samples.
Main Methods:
- Fabrication of a high-density microfluidic SPRi chip.
- Utilizing various immobilization chemistries for targeted analyte capture.
- Implementing controlled recovery of bound biomarkers for subsequent mass spectrometry analysis.
Main Results:
- Demonstrated successful fabrication and operation of the microfluidic SPRi instrument.
- Showcased controlled recovery of bound biomarkers for identification.
- Successfully identified activated leukocyte cell adhesion molecule (ALCAM) from human crude cell lysates.
Conclusions:
- The developed microfluidic SPRi instrument provides a reliable, label-free method for detecting molecular binding.
- The system enables multiplexed analysis and biomarker identification from complex biological samples.
- This technology holds significant potential for advancing medical diagnostics and cancer biomarker research.
